These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 27011685)
61. Levosimendan: a retrospective single-center case series. Berry WT; Hewson RW; Langrish CJ; McKenzie CA; Barrett NA J Crit Care; 2013 Dec; 28(6):1075-8. PubMed ID: 23998721 [TBL] [Abstract][Full Text] [Related]
62. Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Gaies MG; Gurney JG; Yen AH; Napoli ML; Gajarski RJ; Ohye RG; Charpie JR; Hirsch JC Pediatr Crit Care Med; 2010 Mar; 11(2):234-8. PubMed ID: 19794327 [TBL] [Abstract][Full Text] [Related]
64. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. Nieminen MS; Akkila J; Hasenfuss G; Kleber FX; Lehtonen LA; Mitrovic V; Nyquist O; Remme WJ J Am Coll Cardiol; 2000 Nov; 36(6):1903-12. PubMed ID: 11092663 [TBL] [Abstract][Full Text] [Related]
65. Pharmacokinetics of levosimendan in pediatric patients evaluated for cardiac surgery. Turanlahti M; Boldt T; Palkama T; Antila S; Lehtonen L; Pesonen E Pediatr Crit Care Med; 2004 Sep; 5(5):457-62. PubMed ID: 15329162 [TBL] [Abstract][Full Text] [Related]
66. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure. Kivikko M; Lehtonen L Curr Pharm Des; 2005; 11(4):435-55. PubMed ID: 15725064 [TBL] [Abstract][Full Text] [Related]
67. Cardiovascular effects of levosimendan during rewarming from hypothermia in rat. Dietrichs ES; Håheim B; Kondratiev T; Sieck GC; Tveita T Cryobiology; 2014 Dec; 69(3):402-10. PubMed ID: 25280932 [TBL] [Abstract][Full Text] [Related]
68. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079 [TBL] [Abstract][Full Text] [Related]
69. Experiences of levosimendan as an inotropic agent in conjunction with passive containment surgery. Bredin F; Franco-Cereceda A Scand Cardiovasc J; 2007 Jun; 41(3):197-200. PubMed ID: 17487771 [TBL] [Abstract][Full Text] [Related]
70. Incidence and Predictors of Postoperative Need for High-Dose Inotropic Support in Patients Undergoing Cardiac Surgery for Infective Endocarditis. Belletti A; Jacobs S; Affronti G; Mladenow A; Landoni G; Falk V; Schoenrath F J Cardiothorac Vasc Anesth; 2018 Dec; 32(6):2528-2536. PubMed ID: 29338996 [TBL] [Abstract][Full Text] [Related]
71. Levosimendan in congenital cardiac surgery: a randomized, double-blind clinical trial. Momeni M; Rubay J; Matta A; Rennotte MT; Veyckemans F; Poncelet AJ; Clement de Clety S; Anslot C; Joomye R; Detaille T J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):419-24. PubMed ID: 20829069 [TBL] [Abstract][Full Text] [Related]
72. Assessment of Risk Factors for a Sustainable "On-Table Extubation" Program in Pediatric Congenital Cardiac Surgery: 5-Year Experience. Joshi RK; Aggarwal N; Agarwal M; Dinand V; Joshi R J Cardiothorac Vasc Anesth; 2016 Dec; 30(6):1530-1538. PubMed ID: 27618336 [TBL] [Abstract][Full Text] [Related]
73. Comparison of levosimendan and nitroglycerine in patients undergoing coronary artery bypass graft surgery. Sahu MK; Das A; Malik V; Subramanian A; Singh SP; Hote M Ann Card Anaesth; 2016; 19(1):52-8. PubMed ID: 26750674 [TBL] [Abstract][Full Text] [Related]
74. Levosimendan for weaning from cardiopulmonary bypass after coronary artery bypass grafting. Akgul A; Mavioglu L; Katircioglu SF; Pac M; Cobanoglu A Heart Lung Circ; 2006 Oct; 15(5):320-4. PubMed ID: 16860605 [TBL] [Abstract][Full Text] [Related]
75. [Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children]. Prijić S; Rakić S; Nikolić L; Jovicić B; Stajević M; Vukomanović V; Kosutić J Vojnosanit Pregl; 2011 Nov; 68(11):979-84. PubMed ID: 22191317 [TBL] [Abstract][Full Text] [Related]
77. Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function. Eriksson HI; Jalonen JR; Heikkinen LO; Kivikko M; Laine M; Leino KA; Kuitunen AH; Kuttila KT; Peräkylä TK; Sarapohja T; Suojaranta-Ylinen RT; Valtonen M; Salmenperä MT Ann Thorac Surg; 2009 Feb; 87(2):448-54. PubMed ID: 19161758 [TBL] [Abstract][Full Text] [Related]
78. [Effects of levosimendan on hemodynamics and cardiac function in patients with septic shock]. Fang M; Dong S Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Oct; 26(10):692-6. PubMed ID: 25315937 [TBL] [Abstract][Full Text] [Related]
79. Haemodynamic interactions between the novel calcium sensitiser levosimendan and isosorbide-5-mononitrate in healthy subjects. Sundberg S; Lehtonen L Eur J Clin Pharmacol; 2000; 55(11-12):793-9. PubMed ID: 10805056 [TBL] [Abstract][Full Text] [Related]
80. Comparative Effect of Levosimendan and Milrinone in Cardiac Surgery Patients With Pulmonary Hypertension and Left Ventricular Dysfunction. Mishra A; Kumar B; Dutta V; Arya VK; Mishra AK J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):639-46. PubMed ID: 27321790 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]